“Patterns Of Hedgehog Inhibitor (HHI) Treatment Interruptions and Reinitiations Among Patients with Basal Cell Carcinoma (BCC) in Real-World Clinical Practice” (2020) SKIN The Journal of Cutaneous Medicine, 4(6), p. s123. doi:10.25251/skin.4.supp.123.